Track topics on Twitter Track topics that are important to you
The first tranche of a funding round led by Boston Scientific has pulled in $7 million for RenovoRx, bringing the company clo -More-
After receiving feedback from industry and other stakeholders, FDA has revised its "working model" for its planned pre-certification program for...
US FDA says that previously identified elevated risks of type III endoleaks from endovascular aneurysm repair systems appears to be...
Company’s RenovoCath System Has Received Orphan Drug Designation from the FDA for its Innovative Approach RenovoRx, Inc., a medical technology company developing an innovati...
RenovoRx, Inc., based in Silicon Valley, is a medical device company developing novel catheter-based technologies for targeted delivery of fluids to the peripheral vessels. The co...
We have published hundreds of RenovoRx, Inc. news stories on BioPortfolio along with dozens of RenovoRx, Inc. Clinical Trials and PubMed Articles about RenovoRx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RenovoRx, Inc. Companies in our database. You can also find out about relevant RenovoRx, Inc. Drugs and Medications on this site too.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...